DRIO · DarioHealth Corp. · Documents

$2.38 -0.35 (-12.84%) At close · Nov 6 Q1 2026 earnings call transcript

Market Cap

$23.27M

9.80M

Volume · Nov 6 14.9K Avg daily vol (3M) 38.18K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2022

Dec 30

Registration statement S-3

Registration statement

Dec 7

Current report 8-K

Director or officer change, or executive pay, Shareholder vote results

Nov 14

Quarterly report 10-Q FY2022 Q3, ended Sep 30

Quarterly report for FY2022 Q3

Revenue $6.61M ▲ 17.3% Net loss $15.63M Diluted EPS $0.64 ▼ 45.8%

Oct 14

Proxy statement DEF 14A Meeting Dec 7, 2022

Proxy statement

Oct 3

Current report 8-K

Shareholder director nominations

Sep 30

Earnings call

Q3 2022 earnings call

Aug 15

Earnings call

Q2 2022 earnings call

Aug 15

Current report 8-K

Financial results

Aug 15

Quarterly report 10-Q FY2022 Q2, ended Jun 30

Quarterly report for FY2022 Q2

Revenue $6.18M ▲ 17.5% Net loss $18.03M Diluted EPS $0.74 ▼ 25.3%

Jul 1

Registration statement S-3

Registration statement

Jun 13

Current report 8-K Events of Jun 9

Entered into a material agreement, New debt or off-balance-sheet obligation, Other events

Jun 6

Current report 8-K Events of May 30

Director or officer change, or executive pay

May 12

Quarterly report 10-Q FY2022 Q1, ended Mar 31

Quarterly report for FY2022 Q1

Revenue $8.06M ▲ 124.2% Net loss $15.92M Diluted EPS $0.74 ▼ 19.6%

Apr 1

Current report 8-K Events of Mar 31

Completed an acquisition or sale of assets

Mar 31

Earnings call

Q1 2022 earnings call

Mar 22

Annual report 10-K FY2021, ended Dec 31

Annual report for FY2021

Revenue $20.51M ▲ 170.8% Net loss $76.76M Diluted EPS $4.07 ▲ 1.5%

Mar 4

Current report 8-K Events of Feb 28

Entered into a material agreement

Mar 2

Current report 8-K Events of Feb 28

Entered into a material agreement, Other events

Jan 19

Earnings call

Q4 2021 earnings call

Jan 19

Current report 8-K Events of Jan 18

Entered into a material agreement, Financial results

2021

Nov 29

Current report 8-K Events of Nov 25

Director or officer change, or executive pay

Nov 15

Quarterly report 10-Q FY2021 Q3, ended Sep 30

Quarterly report for FY2021 Q3

Revenue $5.63M ▲ 175.7% Net loss $22.44M Diluted EPS -$1.18

Oct 22

Current report 8-K

Entered into a material agreement

Oct 22

Registration statement S-3

Registration statement

Sep 30

Earnings call

Q3 2021 earnings call

Aug 16

Earnings call

Q2 2021 earnings call

Aug 16

Current report 8-K

Financial results

Aug 16

Quarterly report 10-Q FY2021 Q2, ended Jun 30

Quarterly report for FY2021 Q2

Revenue $5.26M ▲ 194.4% Net loss $17.77M Diluted EPS -$0.99

Jul 9

Current report 8-K Events of Jul 8

Charter or bylaw amendment, or fiscal year change, Other events

Jun 8

Current report 8-K Events of Jun 7

Completed an acquisition or sale of assets, Other events

Jun 7

Current report 8-K

Director or officer change, or executive pay, Shareholder vote results

May 18

Current report 8-K Events of May 15

Entered into a material agreement, Regulation FD disclosure, Other events

May 17

Quarterly report 10-Q FY2021 Q1, ended Mar 31

Quarterly report for FY2021 Q1

Revenue $3.6M ▲ 115.7% Net loss $14.97M

Apr 26

Proxy statement DEF 14A Meeting Jun 7, 2021

Proxy statement

Apr 16

Proxy statement PRE 14A Meeting Jun 7, 2021

Proxy statement

Apr 1

Current report 8-K/A Events of Feb 1

Completed an acquisition or sale of assets

Apr 1

Registration statement S-3

Registration statement

Mar 31

Earnings call

Q1 2021 earnings call

Mar 9

Annual report 10-K FY2020, ended Dec 31

Annual report for FY2020

Revenue $7.58M ▲ 0.2% Net loss $29.45M

Feb 4

Current report 8-K Events of Feb 1

Completed an acquisition or sale of assets, Director or officer change, or executive pay, Regulation FD disclosure

Jan 28

Current report 8-K Events of Jan 26

Entered into a material agreement, Unregistered sale of equity, Regulation FD disclosure, Other events

2020

Dec 31

Earnings call

Q4 2020 earnings call

Nov 12

Quarterly report 10-Q FY2020 Q3, ended Sep 30

Quarterly report for FY2020 Q3

Revenue $2.04M ▲ 9.3% Net loss $6.55M

Oct 14

Current report 8-K

Director or officer change, or executive pay, Shareholder vote results

Sep 30

Earnings call

Q3 2020 earnings call

Sep 8

Registration statement S-3

Registration statement

Sep 2

Proxy statement DEF 14A Meeting Oct 14, 2020

Proxy statement

Aug 12

Quarterly report 10-Q FY2020 Q2, ended Jun 30

Quarterly report for FY2020 Q2

Revenue $1.79M ▲ 8.2% Net loss $4.01M

Jul 31

Current report 8-K Events of Jul 28

Entered into a material agreement, Unregistered sale of equity

Jul 6

Current report 8-K Events of Jul 2

Director or officer change, or executive pay

Showing 101–150 of 163 documents

Key facts CIK 1533998 CUSIP 23725P308 13F (30d) 12 filings 6 filers Visit website Investor relations